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19th CardioVascular Summit: TCTAP 2014TCTAP C-141
Hybrid Revascularization Procedure in Patient with Multivessel Coronary
Disease Presenting with Unstable Angina
Krzysztof Milewski, Buszman Pawel
American Heart of Poland, Poland
[Clinical Information]
Patient initials or identiﬁer number:
W.C.
Relevant clinical history and physical exam:
A 63 years old male presenting with unstable angina and multivessel coronary disease.
His medical history included hypertonia arterialis, diabetes mellitus type 2, hyper-
lipidemia, varicose veins, obesity and smoking history.
Relevant test results prior to catheterization:
Echocardiographic assessment before the procedure showed ejection fraction of 56%,
hypokinesis of IVS and inferior wall. The valves were normal. The main laboratory
parameters on admission were as follows: HGB 14.7 g/dl, Platelets 138 G/L, GFR
55.40 ml/min, TnI <0.010 ng/ml. ECG was within a normal range with Q wave in
lead III.
Relevant catheterization ﬁndings:
The main ﬁndings by coronarography were: (1) critical stenosis in proximal part of
LAD, (2) critical stenosis in proximal part of Cx, (3) signiﬁcant stenosis of 80% in
proximal part of RCA.
[Interventional Management]
Procedural step:
Despite unquestionable advantages of percutaneous coronary interventions (PCI) and
coronary artery bypass graft (CABG) surgery, these methods have some inherent lim-
itations which incline for implementing into clinical practice the new hybrid revascu-
larization technique, which combines the best elements of both PCI and CABG. This
includes new generation antiplatelet agents and drug eluting stents with proven safety
and efﬁcacy and arterial grafting of LAD using left internal mammary artery (LIMA).
In the view of MVD with relatively simple lesions located in RCA and Cx and critical
stenosis located in proximal LAD the patient was offered hybrid procedure which
became frequently used and evaluated in our center.
The procedure was performed in the novel state-of-the art hybrid room, under general
anaesthesia. In order to maximize myocardial perfusion and reduce the risk of
myocardial necrosis, PCI of Cx and RCA was initially performed with the use of two
everolimus eluting stents (Promus, Boston Scientiﬁc). This was followed by LIMA-
LAD grafting with subsequent contrast injection in order to check graft patency.
As per protocol, the patient received ticagrelor in a dose of 180mg 12 hours prior to
the procedure and this was continued for the remaining period of 12 months. It was
accompanied by acetylacetylic acid, beta-blocker and statin (rosuvastatin). Despite the
DAPT was initiated before the procedure no excessive bleeding was observed. Im-
mediate postprocedural angiography of the treated coronaries showed excellent result
with TIMI 3 ﬂow. LIMA and anastomosis were patent with good distal perfusion.
During hospitalization no complications were observed and patient remained in
overall good condition. At discharge, the patient reported a marked improvement in
the functional and angina status.
At 1 month follow-up he remained in a good general condition without symptoms of
ischemia or dyspnea.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/CASE/Drug-eluting Stents S155
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19th CardioVascular Summit: TCTAP 2014Case Summary:
Hybrid procedure was safe and feasible. It provides opportunity of complete revas-
cularization during single procedure combining the best elements of both PCI and
CABG.
TCTAP C-142
Dislodged Stent Due to Stent Delivery Balloon Rupture
Nobuyuki Miyai
Kouseikai Takeda Hospital, Japan
[Clinical Information]
Patient initials or identiﬁer number:
SN
Relevant clinical history and physical exam:
The case is a 81-year-old Japanese female.
Her coronary risk factor was diabetes mellitus, dyslipidemia, and hypertension.
She had chest discomfort during some activity. She was suspicious of ischemic cor-
onary artery disease and admitted to our hospital.
She had severe difﬁculty in hearing and speaking.
Relevant test results prior to catheterization:
Electrocardiogram showed sinus rhythm and no ST-T change.
Echocardiogram revealed good cardiac function.
Relevant catheterization ﬁndings:
Coronary angiography revealed signiﬁcant stenosis of mid-portion of the left
ascending coronary artery (LAD).
[Interventional Management]
Procedural step:
Target lesion was the mid-portion of LAD. The coronary system was cannulated using
a 5 Fr IL3.5 guiding catheter by right radial artery approach. The SHION wire was
advanced and we performed Intravascular ultrasound (IVUS) study. We conﬁrmed a
ring-like calciﬁcation in the proximal of the target lesion. So, the lesion was predilated
with a 2.5mmx13mm diameter Lacross non slip element balloon (NSE). When we
inﬂated with the NSE at 12 atm, the NSE was ruptured. Then, we used a
3.0mmx15mm diameter high pressure balloon. When we inﬂated this balloon at
16atm, the indentation of balloon was disappeared. So, we advanced a 3.0mmx28mm
diameter Xience Prime stent at the mid portion of LAD. When we inﬂated with the
stent until 8 atm, the stent delivery balloon was ruptured. We could not expand the
stent again by this stent delivery balloon. The proximal site of the stent was slightly
expanded and the distal site of the stent was ﬁtted on the stent delivery balloon. So,
when we pulled the balloon, this stent could move together. But, the proximal edge of
the stent was caught at the tip of the guiding catheter and we could not retrieve into the
guiding catheter. We engaged a 7Fr JL3.5 guiding catheter via right femoral artery.
We captured the stent by a snare wire. But, it was difﬁcult to retrieve the stent because
the distal site of the stent was fastened on the balloon. We rubbed off the stent from
the balloon with the two guiding catheter and successfully retrieved the stent. We
performed IVUS study again and deployed a 3.0x28mm diameter Nobori stent at the
mid-portion of LAD. We expanded the stent with a 3.0mmx18mm diameter high
pressure balloon and the ﬁnal angiogram showed TIMI 3 grade ﬂow.
Case Summary:
We performed PCI for the mid-portion of LAD. When we inﬂated with the 3.0mm x
28mm diameter Xience Prime stent until 8 atm, the stent delivery balloon was
ruptured. We could not expand the stent again. So, we retrieved the stent.
TCTAP C-143
Absorb Stenting in Acute STEMI: How I Did It
Ansul Patodia, Rohit Manoj
PGIMER, Chandigarh, India
[Clinical Information]
Patient initials or identiﬁer number:
Patient gk, 50 years male
Relevant clinical history and physical exam:
Rest angina from last 3 hours
Relevant test results prior to catheterization:
Echo: severe hypokinesia of LAD territory, LVEF 35%
[Interventional Management]
Procedural step:
1. Guide ebu 3.5: LAD/D1 Bifurcation Lesion
2. Uniform expansion of 2.5 x 15 mm lad ballon.
3. Absorb stent 3x28 mm positioned in proximal to mid lad.
4. Absorb stent remained underexpanded.
5. Check angio: waist persisting.
6. Post dilated with quantum 3.5x8mm ballon @ high pressure.
7. Uniform expansion of LAD stent.
Patient was ﬁne.
Case Summary:
Patient gk, 50 years male with Rest angina from last 3 hours admitted in our institute
for PTCA. Absorb (BVS) was deployed & Patient was ﬁne.
Take home message from this case is Operator has implanted 40 absorb stents and two
out of 40 was deployed in setting of acute MI .Although data is limited absorb can be
used in acute MI setting.S156 JACC Vol 63/12/Suppl STCTAP C-144
Biovascular Scaffold Recoil
Karthik Tummala, Jabir Abdullakutty, Rony Mathew
Lisie Hospital, India
[Clinical Information]
Patient initials or identiﬁer number:
TSV
Relevant clinical history and physical exam:
A 50 years old male
Newly detected Diabetic, Hypertensive & Dyslipidemic
No family h/o CAD
Recent onset dyspnea, NYHA class II
Relevant test results prior to catheterization:
Good LV function, no Regional wall motion abnormality
TMT – positive for inducible ischemia
Relevant catheterization ﬁndings:
Single vessel disease
[Interventional Management]
Procedural step:
Right Radial approach, 6F EBU 3.5 coronary guide was used to cannulate the Left
main.Abott 0.014" Balanced middle weight wire was used to wire the Left anterior
descending artery.The lesion distally was pre dilated with a Boston Maverick 3x15
balloon at 14 atm, check angiogram showed a residue of 70 % stenosis.A serial pre-
dilatation was done with Boston Maverick 3 x 15 at 12-14 atm.The lesion was stented
with Absorb BVS 3.5 X 28 mm at 12 atm. There was a residue to 50 % in check
angio.then the stented area was post dilated with non-compliant Boston QantumMaverick
Balloon 3.5 x 8 mm at 18 atm and non-compliant Balloon 4x 8 mm at 18 atm serially.
During balloon dilatation the vessel goes to 3.5 mm and recoils after deﬂation.There was
a residue of 40% in the stented area in the distal LAD.The proximal LAD lesion was
predilated with Boston Maverick 3.5 x 15 balloon at 12 atm, and was stented with Absorb
3.5 x 18 mm at 12 atm with an overlap into the distal stent.Then the stented area was post
dilated with Boston QantumMaverick Balloon 4x 8 mmnon-compliant balloon at 16 atm.
Case Summary:
There is a acute recoil of the vessel after angioplasty and the biovascular scaffold goes
along with the recoil without much radial support.
TCTAP C-145
A Case of Very Late Stent Thrombosis and Stent Fracture: A Serial Optical
Coherence Tomography Study
Tomoyuki Yamaguchi
Wakayama Medical University, Japan
[Clinical Information]
Patient initials or identiﬁer number:
S.H
Relevant clinical history and physical exam:
Hypertenton, chronic renal failure
[Interventional Management]
Procedural step:
We performed follow-up coronary angiography three years after implantation of
paclitaxel-eluting stent (PES) and suggested stent thrombosis in the PES. We detected
stent structure and thrombus by optical coherence tomography.
Case Summary:
Very late stent thrombosis (VLST) after drug-eluting stent implantation is rare, but a
serious complication. Causes of VLST remain unclear. We experienced a suggestive
case of amechanism for stent thrombosis. A 55 years-old-manwas implanted paclitaxel-
eluting stent tomid-portion of right coronary artery (RCA) for effort angina about 3 years
ago. He again suffered from effort angina 2 years ago, and coronary angiography (CAG)
showed progressive stenosis of proximal region of RCA. He was implanted another
everolimus-eluting stent to proximal region of the PES. Optical coherence tomography
(OCT) presented late acquired malappositon in the PES, but we didn’t perform addi-
tional intervention. Three years after the ﬁrst coronary intervention, CAG showed stent
thrombosis in the PES. OCT revealed thrombosis and stent fracture of the PES. Serial
OCT examination exposed one cause of stent thrombosis.
TCTAP C-146
Recurrent Syncope Due to Anomalous RCA
Yian Yao, Liu Xue Bo
Shanghai East Hospital Tongji University, China
[Clinical Information]
Patient initials or identiﬁer number:
guodaxiong
Relevant clinical history and physical exam:
M, 74 years old
Chief complaint: Recurrent syncope for 15 time in 13 years; syncope happened almost
happened in every half year, syncope could happened in anywhere and any situation
Concomitant symptom: substernal pain, usually occurred in night, and when pain
persistent syncope would happened. And no palpitation or cold sweat
History: Hypertension for 20 years, BP controlled well. Denied diabetes, Smoking.
Relevant test results prior to catheterization:
No abnormal Lab Examination (blood routine, liver function and renal function)j April 22–25, 2014 j TCTAP Abstracts/CASE/Drug-eluting Stents
